356 related articles for article (PubMed ID: 12847397)
1. Endothelial cells play an important role in the antiaggregatory effect of nitric oxide.
Klinge JM; Topf HG; Trusen B; Rauh M; Rascher W; Dötsch J
Crit Care Med; 2003 Jul; 31(7):2010-4. PubMed ID: 12847397
[TBL] [Abstract][Full Text] [Related]
2. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.
Jurasz P; Sawicki G; Duszyk M; Sawicka J; Miranda C; Mayers I; Radomski MW
Cancer Res; 2001 Jan; 61(1):376-82. PubMed ID: 11196190
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide and platelet energy metabolism.
Tomasiak M; Stelmach H; Rusak T; Wysocka J
Acta Biochim Pol; 2004; 51(3):789-803. PubMed ID: 15448739
[TBL] [Abstract][Full Text] [Related]
5. Platelet activation triggered by Chlamydia pneumoniae is antagonized by 12-lipoxygenase inhibitors but not cyclooxygenase inhibitors.
Kälvegren H; Andersson J; Grenegård M; Bengtsson T
Eur J Pharmacol; 2007 Jul; 566(1-3):20-7. PubMed ID: 17459368
[TBL] [Abstract][Full Text] [Related]
6. Inhibition by nitric oxide-releasing compounds of prostacyclin production in human endothelial cells.
Kosonen O; Kankaanranta H; Malo-Ranta U; Ristimäki A; Moilanen E
Br J Pharmacol; 1998 Sep; 125(2):247-54. PubMed ID: 9786495
[TBL] [Abstract][Full Text] [Related]
7. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men.
Adams MR; Forsyth CJ; Jessup W; Robinson J; Celermajer DS
J Am Coll Cardiol; 1995 Oct; 26(4):1054-61. PubMed ID: 7560599
[TBL] [Abstract][Full Text] [Related]
8. Oxidized LDL and reduction of the antiaggregating activity of nitric oxide derived from endothelial cells.
Minuz P; Lechi C; Gaino S; Bonapace S; Fontana L; Garbin U; Paluani F; Cominacini L; Zatti M; Lechi A
Thromb Haemost; 1995 Oct; 74(4):1175-9. PubMed ID: 8560431
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide induces angiogenesis and upregulates alpha(v)beta(3) integrin expression on endothelial cells.
Lee PC; Kibbe MR; Schuchert MJ; Stolz DB; Watkins SC; Griffith BP; Billiar TR; Shears LL
Microvasc Res; 2000 Nov; 60(3):269-80. PubMed ID: 11078643
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.
Salvemini D; Currie MG; Mollace V
J Clin Invest; 1996 Jun; 97(11):2562-8. PubMed ID: 8647949
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-2 in platelet adhesion to fibrinogen: interactions with nitric oxide.
Martinez A; Salas E; Radomski A; Radomski MW
Med Sci Monit; 2001; 7(4):646-51. PubMed ID: 11433190
[TBL] [Abstract][Full Text] [Related]
12. Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors.
Kobzar G; Mardla V; Samel N
Platelets; 2011; 22(5):338-44. PubMed ID: 21557683
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin.
Chakraborty K; Khan GA; Banerjee P; Ray U; Sinha AK
Platelets; 2003; 14(7-8):421-7. PubMed ID: 14713511
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin elicits dilation of isolated porcine retinal arterioles: role of nitric oxide and mevalonate-rho kinase pathways.
Nagaoka T; Hein TW; Yoshida A; Kuo L
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):825-32. PubMed ID: 17251484
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide mediates interactions between GABAA receptors and adenosine A1 receptors in the rat hippocampus.
Fragata IR; Ribeiro JA; Sebastião AM
Eur J Pharmacol; 2006 Aug; 543(1-3):32-9. PubMed ID: 16831416
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.
Sogo N; Magid KS; Shaw CA; Webb DJ; Megson IL
Biochem Biophys Res Commun; 2000 Dec; 279(2):412-9. PubMed ID: 11118301
[TBL] [Abstract][Full Text] [Related]
17. The long-term exposure of endothelial cells to molsidomine increases their antithrombogenicity by inducing the production of nitric oxide-related chemical substances.
Berenger-Bahuet FP; Rolland PH
J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S98-105. PubMed ID: 2484710
[TBL] [Abstract][Full Text] [Related]
18. Regulatory role of nitric oxide over extracellular taurine in the hippocampus of freely moving rats.
Watts J; Segieth J; Pearce B; Whitton PS
Neurosci Lett; 2004 Mar; 357(3):179-82. PubMed ID: 15003279
[TBL] [Abstract][Full Text] [Related]
19. The calcium modulator nifedipine exerts its antiaggregatory property via a nitric oxide mediated process.
Berkels R; Klaus W; Boller M; Rösen R
Thromb Haemost; 1994 Aug; 72(2):309-12. PubMed ID: 7831670
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide inhibits migration of cultured endothelial cells.
Lau YT; Ma WC
Biochem Biophys Res Commun; 1996 Apr; 221(3):670-4. PubMed ID: 8630019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
